myBiometry

myBiometry is a healthcare technology company dedicated to improving respiratory care for patients with chronic diseases, particularly asthma and chronic obstructive pulmonary disease (COPD). The company has developed a platform that utilizes software and biomarker data to remotely monitor and manage these patients. Their innovative approach includes intelligent diagnostics and connected monitoring, allowing for early detection of exacerbations up to 20 days in advance. This empowers patients with actionable biological data to help predict and prevent attacks at home. Headquartered in Massachusetts with operations in Indiana, myBiometry is led by Bryan Nolan, who has extensive experience in healthcare and holds multiple patents. The company is currently developing its flagship product, fenoTRACK, which aims to provide early warnings of respiratory exacerbations. Their services focus on remote patient monitoring, early detection of exacerbations, and delivering actionable health data to enhance disease management for patients and healthcare providers. MyBiometry collaborates with healthcare organizations to support better management of chronic diseases.

• Employees 20